The three LPA1 inhibitors were able to completely inhibit PA-stimulated cell migration at concentrations that were not toxic for the cells (Figure 7D,E), suggesting that LPA1 is the receptor mediating the PA stimulation of lung cancer cell migration. This evidence concerns the gene LPAR1 and lung cancer.